Furthermore, GPC3 levels in 25 HCC serum samples were detected by the proposed Affimer-MAb CLIA assay and three other commercially available dual-MAbs kits (DaRui CLIA kit, Abnova ELISA kit, and R&D ELISA kit). Here, GPC3 is linked to hepatocellular carcinoma.